SCHEMBL2874895

SCHEMBL2874895

CCC(C)C(CN)N(C(=O)c1ccc(Cl)cc1Cl)c1cc(-c2ccccc2)sc1OC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 4/20 0.33
HPGD P15428 4/20 0.33
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KIF11 P52732 1/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.33
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2874891 0.88 CYP3A4 (0.36) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3809084 0.86 CYP1A2 (0.39) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3814750 0.84 CYP1A2 (0.36) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3816891 0.84 CYP1A2 (0.38) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3809481 0.83 CYP1A2 (0.37) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3808899 0.83 PDK1 (0.37) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3811515 0.83 ALDH1A1 (0.38) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3807407 0.82 IKBKB (0.36) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13093847 0.81 CYP3A4 (0.38) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6250386 0.80 CYP3A4 (0.40) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed